New University Certificate for clinical trials

The Clinical Sciences Department of the Medicine Faculty of the University of Liège organizes from the academic year 2018-2019 a University Certificate in clinical trials. More information is available in this folder

A new gene responsible for juvenile myoclonic epilepsy?

In collaboration with a team at the University of California at Los Angeles (UCLA), researchers from GIGA-Neurosciences have discovered a new gene responsible for a seizure syndrome called juvenile myoclonic epilepsy (JME). This discovery was made as part of an international consortium that studies genetic abnormalities responsible for epileptic diseases. It is being published this week in

New technologies available at the GIGA Imaging platform

The LIGHTSHEET MICROSCOPY can deliver optical sections, 3D reconstructions and timelapse movies of whole sample volumes at subcellular resolutions. The fast scan speeds and low phototoxicity of the lightsheet allow to record the development of fluorescent transgenic animals over long time periods, such as zebrafish embryos. Alternatively 3D reconstructions of fixed whole organs or whole embryos,

A team from the University of Liège has discovered a new crosstalk between the migrating inhibitory interneurons and the stem cells that generate the excitatory neurons

The researchers discovered that this cellular dialogue controls the growth of the cerebral cortex and that its impairment leads a cortical malformation previously associated with autism in mice . Their results are published in the prestigious scientific journal Cell. The cerebral cortex contains excitatory and inhibitory interneurons. The former are produced locally and move by

VitriCell raises over €1 million ($1.2M) in series A funding

Liège, Belgium, January 23, 2018 – VitriCell SA, a biotech company providing innovative and efficient solutions for cryopreservation of even the most sensitive cells, discloses today that it closed a series A round of fundraising in the second half of 2017 totaling over €1 million ($1.2M). This consists of equity capital of €712,000 ($872K) from

A gammaherpesvirus infection can protect against allergic asthma

Bénédicte Machiels and Mickaël Dourcy, under the direction of Laurent Gillet (Laboratory of Immunology-Vaccinology (FARAH)), and their colleagues from ULiège and UGent, investigated the imprinting left by the herpesviruses, and more specifically gammaherpesviruses, on the immune system of their host.  In fact, gammaherpesviruses (including the Epstein-Barr virus, responsible for infectious mononucleosis in humans) are very common viruses having co-evolved with

2017 Annual Meeting of the « Structure et Fonctions des Macromolécules Biologique Bioinformatique et Modélisation » Graduate school

On 10th November 2017, the 11th Annual Meeting of the Graduate school “Structure et Fonctions des Macromolécules Biologiques, Bioinformatique et Modélisation” (SFMBBM) is taking place at the University of Liège. This year’s meeting aims to represent the spectrum of biological macromolecules, from nucleic acids to proteins and their interactions, and from their physiological function to

Gamma-Delta T lymphocytes, promote cervical cancer caused by the papillomavirus

Researchers from the GIGA Cellular and Molecular Immunology Laboratory (led by Nathalie Jacobs) and ULB’s Pharmacotherapy and Pharmaceutical Pharmacy Department (led by David Vermijlen) have investigated unconventional T lymphocytes cells expressing a receptor composed of γ and δ chains, in the specific case of human papillomavirus-induced (HPV) cervical cancer. Of all tumor-infiltrating leukocytes, T cells bearing

A project of the GIGA-Neurosciences awarded by the King Baudouin Foundation

Retinal degeneration diseases, characterized by progressive loss of retinal cells, affect several million of persons worldwide and result in a progressive loss of visual abilities. Currently, there is no effective treatment available for patients suffering from these conditions. Recently, attention has been given to cell replacement therapy using retinal cells derived from induced Pluripotent Stem